Industry News
UQ brain researcher honoured
University of Queensland Associate professor Nancy Pachana has been awarded the 2010 ADC ( Australian Davos Connection ) Future Summit Leadership Award for her contribution to medical understanding of how the brain ages. [ + ]
Full bacterial genome assembly on the desktop with Geneious Pro 5.0
New Zealand science software specialists Biomatters has released the latest version of its Geneious Pro sequence analysis software, which it says will allow users to achieve the full bacterial genome assembly for data from a range of leading sequencers using just a desktop computer. [ + ]
Market Report: Aussie biotechs keep even keel amid cautious week
Declines in banks and miners pulled the S&P/ASX200 Index down today erasing Thursday’s gains and leaving the exchange pretty much where it started the week. [ + ]
Feature: Diagnostics and living to 100
A scraping of buccal cells from the lining of the cheek can predict, with a high measure of reliability, one’s risk of developing Alzheimer’s disease, or determine how far they have already progressed towards dementia. From the ability to predict, comes the prospect of being able to prevent. [ + ]
Prima BioMed gets European product designation
Prima BioMed announced today that its CVac ovarian cancer therapy vaccine has been granted Orphan Medicinal Product Designation by the European Medicines Agency (EMA). [ + ]
Burnett immunology centre gets nod from NATA
The Burnett Institute’s ImmunoMonitoring Facility (IMF) has become first such facility in Victoria, and only the fifth in Australia, to be accredited by the National Association of Testing Authorities of Australia. [ + ]
Cochlear wins major design award
Cochlear has taken out this year’s coveted ‘red dot award:design’ for its Nucleus 5 System, a solution for people with severe to profound hearing loss. [ + ]
New study on bowel cancer treatment
The results of an Australian clinical trial assessing two new treatment approaches for bowel cancer patients unable to withstand chemotherapy were published today in the prestigious medical journal, the Journal of Clinical Oncology. [ + ]
New Aussie biofuels project
AusBiotech will oversee a new federal government funded research project aiming to advance the understanding of second generation biofuels. [ + ]
IP is key for medical tech companies
A study looking at the $300 billion medical technology market has highlighted the need for Australian companies to be more mindful of protecting and promoting their IP if they want to share in the spoils. [ + ]
View of the genome shows large-scale variations
Genetic abnormalities are most often discussed in terms of single nucleotide polymorphisms, SNPs (pronounced "snips"), which are changes in a single unit along the 3 billion nucleotides that make up the entire string of human DNA. [ + ]
Future of computing may lie in organic molecules
Microprocessors today are made from silicon, but future generations of computers may draw on the lessons of biology and even feature organic components. [ + ]
Opinion: How the IVD legislation will impact Australian biotechs
The Therapeutic Goods Administration (TGA) has recently legislated amendments to the medical device regulations which mean that all in vitro diagnostics (IVDs), including laboratory developed tests, will need to be included on the Australian Register of Therapeutic Goods (ARTG) by July 1, 2014. [ + ]
Breakthrough in stem cell culturing
A supply of cultured stem cells for clinical uses is coming closer as Karolinska Institutet researchers culture cells under chemically controlled conditions without the use of animal substances.
[ + ]